GSK plc reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was GBP 7,376 million compared to GBP 7,076 million a year ago. Net income was GBP 1,495 million compared to GBP 749 million a year ago. Basic earnings per share from continuing operations was GBP 0.372 compared to GBP 0.106 a year ago. Diluted earnings per share from continuing operations was GBP 0.366 compared to GBP 0.105 a year ago. Basic earnings per share was GBP 0.371 compared to GBP 0.187 a year ago. Diluted earnings per share was GBP 0.365 compared to GBP 0.185 a year ago.
For the full year, sales was GBP 29,324 million compared to GBP 24,696 million a year ago. Net income was GBP 14,956 million compared to GBP 4,385 million a year ago. Basic earnings per share from continuing operations was GBP 1.108 compared to GBP 0.829 a year ago. Diluted earnings per share from continuing operations was GBP 1.092 compared to GBP 0.818 a year ago. Basic earnings per share was GBP 3.714 compared to GBP 1.096 a year ago. Diluted earnings per share was GBP 3.662 compared to GBP 1.082 a year ago.